Royal commission

Puma Biotechnology Announces Publication of Abstracts on Neratinib for the 2022 ASCO Annual Meeting

Retrieved on: 
Thursday, May 26, 2022 - 10:05pm

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced the publication of two abstracts on neratinib to be presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.

Key Points: 
  • Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced the publication of two abstracts on neratinib to be presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.
  • The ASCO Annual Meeting will be held in person at McCormick Place in Chicago, Illinois, and online from June 3 - 7, 2022.
  • The corresponding abstracts of the two posters that Puma will be presenting are now live on the 2022 ASCO Annual Meeting website.
  • Puma in-licenses the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357.

Elevar Therapeutics Announces Rivoceranib Demonstrated Clinical Effectiveness in Patients with Progressive Recurrent or Metastatic Adenoid Cystic Carcinoma in a Phase 2 Trial

Retrieved on: 
Thursday, May 26, 2022 - 10:00pm

SALT LAKE CITY, May 26, 2022 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options, today announced its Phase 2 clinical trial (Study RM-202) evaluating rivoceranib, an orally administered tyrosine kinase inhibitor (TKI), demonstrated clinical effectiveness in patients with progressive recurrent or metastatic adenoid cystic carcinoma (R/M ACC). Elevar will present topline findings at the American Society of Clinical Oncology (ASCO)’s annual meeting on June 6.

Key Points: 
  • Elevar will present topline findings at the American Society of Clinical Oncology (ASCO)s annual meeting on June 6.
  • It is also gratifying that rivoceranib demonstrates a favorable safety profile, reflecting adverse events consistent with other VEGFR TKIs.
  • Rivoceranib, co-developed by Jiangsu Hengrui Pharmaceuticals Co., Ltd. (JHP) in China and Elevar Therapeutics globally, with the exception of China.
  • Orphan drug designations have been granted in gastric cancer (U.S., EU and South Korea), adenoid cystic carcinoma (U.S.) and hepatocellular carcinoma (U.S.).

Global Wind Automation Market Forecasts Report 2022-2027 Featuring Major Players - Siemens, Rockwell Automation, and Bachmann Electronic - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 26, 2022 - 2:39pm

The growing digital transformation trend, along with rising R&D spending, is expected to be the major factor propelling the growth of the global wind automation market.

Key Points: 
  • The growing digital transformation trend, along with rising R&D spending, is expected to be the major factor propelling the growth of the global wind automation market.
  • One of the main factors driving the growth of the global wind energy automation market is the rising demand for renewable energy.
  • The increasing demand for global wind automation solutions has led to the entry of several new players into the global wind automation market.
  • Major market players like Siemens AG, Rockwell Automation, Inc., and Bachmann Electronic GmbH, among others, have been covered along with their relative competitive strategies.

Recycled Polyethylene Terephthalate Market Size to Reach USD 16.63 Billion in 2030 | Emergen Research

Retrieved on: 
Thursday, May 26, 2022 - 2:30pm

VANCOUVER, BC, May 26, 2022 /PRNewswire/ --The global recycled Polyethylene Terephthalate (rPET) market size reached USD 9.25 Billion in 2021 and is expected to register a significantly rapid revenue CAGR during the forecast period, according to latest analysis by Emergen Research.

Key Points: 
  • VANCOUVER, BC, May 26, 2022 /PRNewswire/ --The global recycled Polyethylene Terephthalate (rPET) market size reached USD 9.25 Billion in 2021 and is expected to register a significantly rapid revenue CAGR during the forecast period, according to latest analysis by Emergen Research.
  • Moreover, heating rPET products for reusability degrades durability, which would gradually lead to being dumped in landfills as waste.
  • The global recycled PET market is expected to register a CAGR of 6.7% over the forecast period and revenue is projected to increase from USD 9.25 Billion in 2021 to USD 16.63 Billion in 2030.
  • Emergen Research has segmented recycled PET market on the basis of type, product, source, application, and region:

Recycled Polyethylene Terephthalate Market Size to Reach USD 16.63 Billion in 2030 | Emergen Research

Retrieved on: 
Thursday, May 26, 2022 - 2:30pm

VANCOUVER, BC, May 26, 2022 /PRNewswire/ --The global recycled Polyethylene Terephthalate (rPET) market size reached USD 9.25 Billion in 2021 and is expected to register a significantly rapid revenue CAGR during the forecast period, according to latest analysis by Emergen Research.

Key Points: 
  • VANCOUVER, BC, May 26, 2022 /PRNewswire/ --The global recycled Polyethylene Terephthalate (rPET) market size reached USD 9.25 Billion in 2021 and is expected to register a significantly rapid revenue CAGR during the forecast period, according to latest analysis by Emergen Research.
  • Moreover, heating rPET products for reusability degrades durability, which would gradually lead to being dumped in landfills as waste.
  • The global recycled PET market is expected to register a CAGR of 6.7% over the forecast period and revenue is projected to increase from USD 9.25 Billion in 2021 to USD 16.63 Billion in 2030.
  • Emergen Research has segmented recycled PET market on the basis of type, product, source, application, and region:

Presearch Community Launches First Decentralized Web3 Search Engine

Retrieved on: 
Thursday, May 26, 2022 - 2:00pm

TORONTO , May 26, 2022 /PRNewswire/ -- Presearch, the private, decentralized search engine with 3.8 million registered users and 150 million monthly searches, today announced its Mainnet launch, shifting all search traffic to run on its decentralized network of community-run nodes.

Key Points: 
  • TORONTO, May 26, 2022 /PRNewswire/ -- Presearch , the private, decentralized search engine with 3.8 million registered users and 150 million monthly searches, today announced its Mainnet launch, shifting all search traffic to run on its decentralized network of community-run nodes.
  • "In a world where one company controls 92 percent of the search engine market and the flow of information for billions of people, there's a clear need for a decentralized, Web3 alternative," said Colin Pape, Founder of Presearch.
  • Now the leader in decentralized search, Presearch has built a growing network of 65,000 nodes run by community operators to power its Testnet search engine.
  • Community-driven and powered by a global network of node operators, Presearch is able to operate as a decentralized search engine.

APWG eCrime 2022 Symposium Examines the Menace and Mutation of Cybercrime in a Time of Continental War and Global Pandemic

Retrieved on: 
Thursday, May 26, 2022 - 1:31am

eCrime 2022 consists of a 3-day program composed of keynote presentations, technical and practical sessions, and interactive panels.

Key Points: 
  • eCrime 2022 consists of a 3-day program composed of keynote presentations, technical and practical sessions, and interactive panels.
  • IMPORTANT DATES FOR eCRIME 2022:
    Accepted papers will be submitted for inclusion into IEEE Xplore subject to meeting IEEE Xplore's scope and quality requirements.
  • APWG is a founding member of the steering group of the Commonwealth Cybercrime Initiative at the Commonwealth of Nations .
  • The conference, founded in 2006 by APWG, is the only peer-reviewed conference dedicated exclusively to cybercrime studies.

Bavarian Nordic Enters First Larger Vaccine Contract with Government in Response to Monkeypox Outbreak

Retrieved on: 
Wednesday, May 25, 2022 - 10:52am

Bavarian Nordic is currently in dialogue with several other governments concerning supply of the vaccine to mitigate the current monkeypox outbreak and to explore opportunities for longer term collaboration to build stockpiles for future preparedness.

Key Points: 
  • Bavarian Nordic is currently in dialogue with several other governments concerning supply of the vaccine to mitigate the current monkeypox outbreak and to explore opportunities for longer term collaboration to build stockpiles for future preparedness.
  • Officially, monkeypox cases have been reported in more than 15 countries as of to-date with numbers continuing to rise.
  • In recent years, the vaccine has been supplied in response to sporadic cases of monkeypox.
  • The vaccine is also approved for protection against smallpox and monkeypox in Canada, and as a smallpox vaccine in Europe.

DGAP-News: Signing of an investor agreement relating to a voluntary public takeover offer by Oaktree and CURA

Retrieved on: 
Tuesday, May 24, 2022 - 11:20pm

r.l., a holding company which will in the future be jointly controlled by affiliates of Oaktree Capital Group Holdings GP, LLC and the limited partnership CURA Vermgensverwaltung G.m.b.H.

Key Points: 
  • r.l., a holding company which will in the future be jointly controlled by affiliates of Oaktree Capital Group Holdings GP, LLC and the limited partnership CURA Vermgensverwaltung G.m.b.H.
  • The Offer values Deutsche EuroShop at an equity value of about EUR 1.4 billion.
  • The Offer represents a premium of 44.0% to the Xetra closing price of the Shares on 20 May 2022 (EUR 15.63).
  • Further information on the Offer will be made available on Deutsche EuroShop's website or by the Bidder after its publication.

DGAP-News: Manz AG: Daimler Truck acquires a stake in Manz as part of a strategic partnership

Retrieved on: 
Tuesday, May 24, 2022 - 11:16pm

The future partners will combine their expertise to jointly develop innovative battery technology and associated production processes for trucks and buses.

Key Points: 
  • The future partners will combine their expertise to jointly develop innovative battery technology and associated production processes for trucks and buses.
  • Manz has decades of experience in process & product development in the battery sector as well as proven expertise in the realization of large-scale projects.
  • The "InnoLab Battery" is thus laying the foundation for the future competence of proprietary battery technology within Daimler Truck.
  • Dr. Andreas Gorbach, Member of the Management of Daimler Truck Holding AG and in this function responsible for Truck Technology: "The partnership between Daimler Truck and Manz forms an essential cornerstone of our battery strategy.